SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004090
Filing Date
2021-11-10
Accepted
2021-11-10 16:17:27
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q harp-20210930.htm   iXBRL 10-Q 3340400
2 EX-10.1 harp-ex10_1.htm EX-10.1 84770
3 EX-31.1 harp-ex31_1.htm EX-31.1 14095
4 EX-31.2 harp-ex31_2.htm EX-31.2 14093
5 EX-32.1 harp-ex32_1.htm EX-32.1 11446
  Complete submission text file 0000950170-21-004090.txt   10631771

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT harp-20210930_def.xml EX-101.DEF 164418
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT harp-20210930_cal.xml EX-101.CAL 42567
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT harp-20210930_pre.xml EX-101.PRE 283254
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT harp-20210930.xsd EX-101.SCH 47855
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT harp-20210930_lab.xml EX-101.LAB 393986
11 EXTRACTED XBRL INSTANCE DOCUMENT harp-20210930_htm.xml XML 2264760
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38800 | Film No.: 211396879
SIC: 2836 Biological Products, (No Diagnostic Substances)